Page last updated: 2024-08-21

pseudouridine and 2019 Novel Coronavirus Disease

pseudouridine has been researched along with 2019 Novel Coronavirus Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Ruffell, D1
Gingras, AC; Sonenberg, N; Svitkin, YV1
Barna, M; Byeon, GW; Cai, H; Choe, C; Das, R; Diaz, F; Dormitzer, PR; Fujii, K; Guo, P; Kerr, CH; Kim, DS; Kladwang, W; Leppek, K; Meng, F; Nicol, JJ; Participants, E; Romano, J; Rothschild, D; Sharma, E; Shi, S; Solórzano, A; Tiu, GC; Topkar, VV; Tunguz, B; Watkins, AM; Wayment-Steele, HK; Wellington-Oguri, R; Wu, J; Xu, AF1
Burgute, BD; Djuranovic, S; Evans, BS; Jing, C; Jungers, C; Kim, KQ; Tzeng, SC; Vierstra, RD; Yan, LL; Zaher, HS; Zhang, J1
Walsh, CT1
Burrows, CJ; Fleming, AM1

Reviews

1 review(s) available for pseudouridine and 2019 Novel Coronavirus Disease

ArticleYear
Covalent Catalytic Strategies for Enzymes That Modify RNA Molecules on their Tripartite Building Blocks.
    ACS chemical biology, 2022, 10-21, Volume: 17, Issue:10

    Topics: Carbon; Catalysis; COVID-19; Cytosine; Glycosides; Guanine; Guanosine Triphosphate; Humans; Nucleoside Q; Nucleotides; Pseudouridine; RNA, Messenger; RNA, Viral; SARS-CoV-2

2022

Other Studies

5 other study(ies) available for pseudouridine and 2019 Novel Coronavirus Disease

ArticleYear
The future in an RNA molecule: from mRNA vaccines to therapeutics - An interview with Drew Weissman.
    FEBS letters, 2021, Volume: 595, Issue:18

    Topics: Antibodies, Monoclonal; Betacoronavirus; Cancer Vaccines; COVID-19; COVID-19 Vaccines; Dendritic Cells; Drug Industry; Genetic Therapy; Humans; Inflammation; Lymphatic System; mRNA Vaccines; Nanoparticles; Precision Medicine; Pseudouridine; RNA Stability; RNA, Messenger; United States; Vaccines, Synthetic

2021
Membrane-dependent relief of translation elongation arrest on pseudouridine- and N1-methyl-pseudouridine-modified mRNAs.
    Nucleic acids research, 2022, 07-22, Volume: 50, Issue:13

    Topics: Animals; COVID-19; Dogs; In Vitro Techniques; Intracellular Membranes; Peptide Chain Elongation, Translational; Peptides; Pseudouridine; Rabbits; RNA, Messenger

2022
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics.
    Nature communications, 2022, 03-22, Volume: 13, Issue:1

    Topics: COVID-19; Humans; Pseudouridine; RNA; RNA Stability; RNA, Messenger

2022
N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products.
    Cell reports, 2022, 08-30, Volume: 40, Issue:9

    Topics: COVID-19; COVID-19 Vaccines; Humans; mRNA Vaccines; Nucleotides; Proteins; Pseudouridine; RNA; RNA, Messenger; Vaccines, Synthetic

2022
Bisulfite and Nanopore Sequencing for Pseudouridine in RNA.
    Accounts of chemical research, 2023, 10-03, Volume: 56, Issue:19

    Topics: COVID-19; Escherichia coli; Humans; Nanopore Sequencing; Pseudouridine; RNA; RNA Processing, Post-Transcriptional; RNA, Ribosomal; SARS-CoV-2

2023